I posted this over at Mako's vehicle of choice, as a reply to KarinCA's most recent article. I'm posting it here so you won't have to go over to SA and give them ad revenue, which they get with every view.

Quote:

---

The Brilacidin-OM (oral mucositis) results that were just released actually were spectacular, but many people do not understand this because of a strange result in the placebo arm.
In the other studies and clinical trials for oral mucositis drugs, the incidence of OM is about 75% to 100% in head and neck cancer patients who receive radiation and/or chemotherapy.
Yet in this study, the oral mucositis rate in the control group was only 60%. This is a huge outlier from all the other research on this condition.
Patients in the Brilacidin arm of the study developed OM 36.8% of the time.
If the usual rate of OM development is in fact 75% -- at the low end of all the other studies' results -- this means that Brilacidin cut the incidence of severe oral mucositis BY HALF.
The 60% placebo rate in this study seems to be an error or a fluke.

If your doctor said "You can swish this rinse 3 times a day, and your risk of a horribly painful and debilitating condition will drop by half," -- would you use the Brilacidin-OM rinse?
Me too.

---